Erasca, Inc. (ERAS): COO Nicholas (Nik) Chetwyn, Ph.D. reason not stated

ERAS · Nasdaq · Pharmaceutical Preparations · <br>Emerging growth company · CA · Form 8-K filed 2026-10-16

Nicholas Chetwyn, Ph.D., Chief Operating Officer, will terminate employment effective November 2, 2026.

Open seatNo successor namedNo reason givenEffective within 30 daysPrincipal officer

Events in this filing

1 event: Departure (COO).

Names, stated reasons, successor status, compensation terms and the evidence quotes are shown to subscribers. See plans

Item 5.02 as filed

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On October 15, 2026, Erasca, Inc. (the Company) decided to realign its leadership responsibilities to support the development and potential commercialization of its RAS-targeting programs. Responsibilities currently overseen by the Chief Operating Officer are transitioning to other members of the Company’s leadership team in order to streamline the Company’s reporting structure. Accordingly, the employment of Nicholas (Nik) Chetwyn, Ph.D., the Company’s Chief Operating Officer, will terminate effective November 2, 2026.

Source filing on EDGAR →